Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 11Phase 1/2 8Phase 3 3Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 1

Status

Unknown 2Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 21Myeloid 3Lymphoid 3Tumor-Agnostic 1Classical hematology 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma, T-Cell, Peripheral 1

Interventions

Rituximab 238Cyclophosphamide 192Vincristine 164Doxorubicin 150Prednisone 126Methotrexate 80Cytarabine 79Etoposide 78Dexamethasone 72Radiotherapy 60Bendamustine Hydrochloride 58Mercaptopurine 46Lenalidomide 42pegaspargase 41Prednisolone 38Filgrastim 38ibrutinib 37fludarabine 36Bleomycin 36Daunorubicin 35obinutuzumab 34Asparaginase 33Leucovorin 29venetoclax 28Granulocyte Colony-Stimulating Factor 28Chlorambucil 27Calcium Dobesilate 27Gemcitabine 26Vinblastine 25Thioguanine 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Decitabine × Lymphoid × Clear all
NCT07348575 2026-01-16

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

Second Affiliated Hospital of Nanchang University

Phase 3 Enrolling by invitation
80 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT05351346 2023-03-24

Genotype-guided Treatment in DLBCL

Ruijin Hospital

Phase 3 Unknown
1,100 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03553537 2018-06-12

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Southwest Hospital, China

Phase 3 Unknown
100 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡